Wall Street Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $245K | Hold |
2,000
| – | – | 0.16% | 191 |
|
|
2016
Q3 | $245K | Hold |
2,000
| – | – | 0.08% | 208 |
|
|
2016
Q2 | $234K | Hold |
2,000
| – | – | 0.09% | 204 |
|
|
2016
Q1 | $278K | Hold |
2,000
| – | – | 0.12% | 187 |
|
|
2015
Q4 | $381K | Hold |
2,000
| – | – | 0.11% | 240 |
|
|
2015
Q3 | $313K | Hold |
2,000
| – | – | 0.06% | 289 |
|
|
2015
Q2 | $362K | Hold |
2,000
| – | – | 0.03% | 302 |
|
|
2015
Q1 | $347K | Hold |
2,000
| – | – | 0.03% | 295 |
|
|
2014
Q4 | $370K | Hold |
2,000
| – | – | 0.04% | 277 |
|
|
2014
Q3 | $332K | Sell |
2,000
-2,965
| -60% | -$492K | 0.03% | 295 |
|
|
2014
Q2 | $776K | Sell |
4,965
-700
| -12% | -$109K | 0.07% | 232 |
|
|
2014
Q1 | $862K | Hold |
5,665
| – | – | 0.07% | 223 |
|
|
2013
Q4 | $753K | Sell |
5,665
-40
| -0.7% | -$5.32K | 0.06% | 238 |
|
|
2013
Q3 | $663K | Sell |
5,705
-100
| -2% | -$11.6K | 0.06% | 239 |
|
|
2013
Q2 | $535K | Buy |
+5,805
| New | +$535K | 0.05% | 232 |
|